Such treatment led to a decrease in binding of Clock to Bmal1 and a downregulation of Bhlhe41 and Dnajb4 expression, resulting in NCLX upregulation and an improvement in mitochondrial calcium overload, hippocampal neuron dysfunction, and cognitive impairment in diabetes. The gene discussed is DNAJB4; the disease is Cognitive impairment.